Skip to main content
. 2019 Oct 17;8(1):1479–1489. doi: 10.1080/22221751.2019.1677177

Table 1. Clinical and other relative information of all cases from four provinces.

Clinical characteristics Hunan N (%) Sichuan N (%) Guizhou N (%) Yunnan N (%) Total N (%)
Case type          
 New 28 (9.7) 21 (7.2) 116 (40) 105 (36.2) 270 (93.1)
 Relapse 3 (1.03) 0 (0) 10 (3.5) 7 (2.41) 20 (6.9)
Gender          
 Male 19 (6.6) 15 (5.1) 89 (30.7) 77 (26.6) 200 (69)
 Female 12 (4.1) 6 (2.1) 37 (12.8) 35 (12) 90 (31)
 Age (mean) 47 47 37 39 42.5
R -J classification          
 TT 1 (0.3) 2 (0.7) 3 (1) 7 (2.4) 13 (4.4)
 BT 2 (0.7) 4 (1.4) 16 (5.6) 31 (10.7) 53 (18.4)
 BB 1 (0.3) 1 (0.3) 8 (2.8) 6 (2) 16 (5.4)
 BL 12 (4.1) 7 (2.4) 60 (20.7) 57 (19.7) 136 (46.9)
 LL 15 (5.2) 7 (2.4) 39 (13.5) 11 (3.8) 72(24.9)
Nerve involvement          
 Yes 22 (7.6) 15 (5.1) 87 (30) 96 (33.1) 220 (75.8)
 No 9 (3.1) 6 (2) 39 (13.5) 16 (5.6) 70 (24.2)
Deformity          
 Yes 13 (4.4) 8 (2.8) 49 (16.9) 33 (11.4) 103 (35.5)
 No 18 (6.2) 13 (4.4) 77 (26.6) 79 (27.3) 187 (64.5)
Reaction          
 Yes 9 (3.1) 2 (0.8) 12 (4.1) 17 (5.8) 40 (13.8)
 No 22 (7.6) 19 (6.6) 114 (39.3) 95 (32.7) 250 (86.2)

Number (percentage); TT-tuberculoid tuberculoid leprosy, BT-borderline tuberculoid leprosy, BB-borderline borderline leprosy, BL-borderline lepromatous leprosy, LL-lepromatous leprosy.